Difference between revisions of "QMS"
(I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâs DNA tests is central to FDAâs concerns. A false positive resu) |
(What do you study? <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">generic depakote side effects</a> Steve Owens, dark skies consultant and chair of the IDA's development comm) |
||
| Line 1: | Line 1: | ||
| − | I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of | + | I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâÂÂs DNA tests is central to FDAâÂÂs concerns. A false positive result could lead consumers to seek unnecessary and possibly harmful screening or treatment, regulators worry, while a false negative could allow a major risk to go unnoticed. FDA found tests predicting a personâÂÂs sensitivity to certain drugs, including the anticoagulant warfarin, to be âÂÂparticularly concerning,â saying that people may change their dosage or discontinue a drug without professional advice. The letter scolds 23andMe for failing to provide evidence to the FDA that its tests work: âÂÂMore than 5 years after you began marketing, you still had not completed some of the studies and had not even started other studies necessary to support a marketing submission for the PGS.â |
Revision as of 14:23, 13 February 2015
I'm on holiday <a href=" http://www.aufildujeu.com/what-is-depakote-er-used-for ">depakote er half life</a> The accuracy of 23andMeâÂÂs DNA tests is central to FDAâÂÂs concerns. A false positive result could lead consumers to seek unnecessary and possibly harmful screening or treatment, regulators worry, while a false negative could allow a major risk to go unnoticed. FDA found tests predicting a personâÂÂs sensitivity to certain drugs, including the anticoagulant warfarin, to be âÂÂparticularly concerning,â saying that people may change their dosage or discontinue a drug without professional advice. The letter scolds 23andMe for failing to provide evidence to the FDA that its tests work: âÂÂMore than 5 years after you began marketing, you still had not completed some of the studies and had not even started other studies necessary to support a marketing submission for the PGS.âÂÂ
